Healthcare
GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is an NSE-listed Healthcare company. latest close ₹2,755, 1-day return +0.8%, 1-week return -1.0%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 5 Oct 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹2,755
- 1-day return
- +0.8%
- 1-week return
- -1.0%
- 1-month return
- -6.9%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 46.2
- ADX (14)
- 29.3
- ROC 10
- -3.8%
- vs 52W high
- -11.7%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹46,756 Cr
- P/E
- 43.7
- P/B
- 20.62
- ROE
- —
- D/E
- 1.47
- Net margin
- 27.0%
- Rev. growth YoY
- -3.7%
- Div. yield
- 2.1%
- 52W high
- ₹3,120.7
- 52W low
- ₹2,088.1
- EPS (TTM)
- ₹63.18
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return +0.8%
Latest 1-day price change versus the previous close.
- signal
1-week return -1.0%
Price change over the last five trading sessions.
- signal
ADX(14) 29 — trend in force
ADX above 25 usually means a directional move is underway.
News & screener mentions
Recent QUANTSCASE daily posts that listed GLAXO.
No recent screener posts mentioned GLAXO yet. New daily posts will show up here automatically.
